2450 studies found for:    "Hepatitis A"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Terminated Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis
Conditions: Acute Hepatitis A;   Acute Hepatitis B;   Acute Hepatitis C;   Acute Hepatitis E;   Acute EBV Hepatitis;   Acute CMV Hepatitis
Interventions: Dietary Supplement: Silymarin;   Other: Lactose monohydrate
2 Completed Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc
Conditions: Hepatitis B;   Hepatitis A
Interventions: Biological: TWINRIX™;   Biological: Engerix™-B;   Biological: HAVRIX™;   Biological: HB VAX PRO™;   Biological: Vaqta™
3 Not yet recruiting Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)
Conditions: Hepatitis B;   Hepatitis A
Intervention: Procedure: Blood sampling
4 Active, not recruiting Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents
Conditions: Hepatitis A;   Hepatitis A Virus
Intervention: Biological: Avaxim 80U Pediatric: Inactivated Hepatitis A Virus
5 Completed Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
Conditions: Liver Diseases;   Hepatitis, Chronic;   Hepatitis, Viral, Human;   Hepatitis;   Virus Diseases;   Digestive System Diseases;   Hepatitis B, Chronic;   Hepatitis B;   DNA Virus Infections
Intervention:
6 Completed
Has Results
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule
Conditions: Hepatitis B;   Hepatitis A
Intervention: Biological: Twinrix™ adult
7 Completed
Has Results
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule
Conditions: Hepatitis B;   Hepatitis A
Interventions: Biological: TWINRIX™ ADULT;   Biological: Engerix TM
8 Completed
Has Results
Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults
Conditions: Hepatitis B;   Hepatitis A
Intervention: Biological: Twinrix™
9 Completed Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults
Conditions: Hepatitis B;   Hepatitis A
Interventions: Biological: Twinrix;   Biological: Engerix-B;   Biological: Havrix;   Biological: HBVAXPRO;   Biological: Vaqta
10 Recruiting Non-invasive Biomarkers of Fibrosis in Pediatric Viral Hepatitis
Conditions: Viral Hepatitis;   Liver Fibrosis;   Liver Disease;   Hepatitis B;   Hepatitis C
Intervention:
11 Unknown  Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
Conditions: Hepatitis C;   Hepatitis B;   Autoimmune Hepatitis;   Liver Cirrhosis, Biliary;   Cholangitis, Sclerosing
Intervention:
12 Completed
Has Results
Lamivudine and Adefovir to Treat Chronic Hepatitis B
Conditions: HBV (Hepatitis B Virus);   Hepatitis B;   Hepatitis
Interventions: Drug: Lamivudine and adefovir;   Drug: Adefovir alone
13 Completed Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C
Conditions: Coinfection With Hepatitis B Virus and Hepatitis C Virus;   Monoinfection With Hepatitis C Virus
Intervention:
14 Unknown  Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
Conditions: Hepatitis B, Chronic;   Hepatitis C, Chronic
Intervention: Drug: Peginterferon Alfa-2a plus Ribavirin
15 Enrolling by invitation A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study
Conditions: Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 1
Interventions: Drug: ABT-450/r;   Drug: ABT-267;   Drug: pegylated interferon alpha-2a (pegIFN);   Drug: Ribavirin (RBV)
16 Completed
Has Results
Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children
Conditions: Hepatitis A Vaccine;   Hepatitis A
Interventions: Biological: Havrix®;   Biological: M-M-R®II;   Biological: VARIVAX®
17 Terminated Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus
Conditions: Chronic Hepatitis;   Hepatitis B
Interventions: Drug: Clevudine;   Drug: Adefovir
18 Recruiting New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
Conditions: Cirrhosis;   Chronic Hepatitis C;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Asunaprevir and Daclatsvir;   Drug: Asunaprevir, daclatsvir, peginterferon, ribavirin
19 Completed Investigation of Hepatitis B and Hepatitis C in Taiwan
Conditions: Hepatitis B;   Hepatitis C
Intervention: Biological: blood sampling and abdominal sonography
20 Completed A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A
Condition: Hepatitis A
Intervention: Biological: Hepatitis A vaccine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years